Vasopressin antagonists for the treatment of acute decompensated heart failure: when, for whom, for how long, and on what standard therapy?
作者信息
Filippatos Gerasimos, Parissis John T
机构信息
Heart Failure Unit, Department of Cardiology, Athens University Hospital Attikon, Athens, Greece.
出版信息
J Card Fail. 2008 Oct;14(8):648-50. doi: 10.1016/j.cardfail.2008.08.003. Epub 2008 Sep 12.
Abstract
摘要
相似文献
1
Vasopressin antagonists for the treatment of acute decompensated heart failure: when, for whom, for how long, and on what standard therapy?
J Card Fail. 2008 Oct;14(8):648-50. doi: 10.1016/j.cardfail.2008.08.003. Epub 2008 Sep 12.
2
Efficacy and safety of the vasopressin V1A/V2-receptor antagonist conivaptan in acute decompensated heart failure: a dose-ranging pilot study.血管加压素V1A/V2受体拮抗剂考尼伐坦在急性失代偿性心力衰竭中的疗效和安全性：一项剂量范围的初步研究。
J Card Fail. 2008 Oct;14(8):641-7. doi: 10.1016/j.cardfail.2008.06.003. Epub 2008 Jul 10.
3
[Vasopressin V2-receptor antagonist, tolvaptan, for treatment of heart failure].血管加压素V2受体拮抗剂托伐普坦用于治疗心力衰竭
Nihon Rinsho. 2007 May 28;65 Suppl 5:164-8.
4
Tolvaptan, an oral vasopressin V2 receptor antagonist for heart failure?
Am J Kidney Dis. 2007 Dec;50(6):904-7. doi: 10.1053/j.ajkd.2007.10.006.
5
The critical link of hypervolemia and hyponatremia in heart failure and the potential role of arginine vasopressin antagonists.心力衰竭中血容量过多和低钠血症的关键环节及精氨酸加压素拮抗剂的潜在作用。
J Card Fail. 2010 May;16(5):419-31. doi: 10.1016/j.cardfail.2009.12.021. Epub 2010 Feb 20.
6
Conivaptan Yamanouchi.考尼伐坦 山之内公司
Curr Opin Investig Drugs. 2005 Mar;6(3):317-26.
7
Novel neurohormonal antagonist strategies: vasopressin antagonism, anticytokine therapy, and endothelin antagonism in patients who have heart failure.新型神经激素拮抗剂策略：心力衰竭患者的血管加压素拮抗、抗细胞因子治疗和内皮素拮抗。
Heart Fail Clin. 2005 Apr;1(1):103-27. doi: 10.1016/j.hfc.2004.12.002.
8
[Heart failure. Can vasopressin antagonists improve the prognosis?].[心力衰竭。血管加压素拮抗剂能否改善预后？]
MMW Fortschr Med. 2003 Nov 27;145(48):10.
9
Role of tolvaptan in acute decompensated heart failure.
Expert Rev Cardiovasc Ther. 2008 Jun;6(5):601-8. doi: 10.1586/14779072.6.5.601.
10
Conivaptan: a selective vasopressin antagonist for the treatment of heart failure.
Expert Rev Cardiovasc Ther. 2006 Jan;4(1):17-23. doi: 10.1586/14779072.4.1.17.
引用本文的文献
1
Can we prevent or treat renal dysfunction in acute heart failure?我们能否预防或治疗急性心力衰竭中的肾功能障碍？
Heart Fail Rev. 2012 Mar;17(2):291-303. doi: 10.1007/s10741-011-9253-3.
Zotero 插件